Concepedia

Frank P. Bymaster

FP

Statistics

Publications

92

Citations

13.3K

H-Index

52

Active since

1974

Affiliations

Eli Lilly (United States)(Current)

Novo Nordisk (Denmark)

National Institute of Diabetes and Digestive and Kidney Diseases

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Frank P. Bymaster is an author at Eli Lilly (United States) specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

1974–2024

92

Publications

92

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Frank P. Bymaster · Neuropsychopharmacology · 2002 · 1.1K citations · Full text

Medicine, Neuroscience, Pharmacology +17

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

Frank P. Bymaster, David O. Calligaro, Julie F. Falcone et al. · Neuropsychopharmacology · 1996 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

Yansheng Du, Zhizhong Ma, Suizhen Lin et al. · Proceedings of the National Academy of Sciences · 2001 · 786 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors

Frank P. Bymaster · Neuropsychopharmacology · 2001 · 720 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

N. Bodick, Walter Offen, Allan I. Levey et al. · Archives of Neurology · 1997 · 685 citations

Medicine, Neurology, Pharmacology +17

1–5 of 92